The decreased expression of the CTLA-4 mRNA and increased expression of its counter-receptor B7-2 (CD86) in the orbital tissue from GO may explain that patients with GD develop severe GO due to the increased autoimmune reactivity in the orbital venue. This evidence concerns the gene CTLA4 and geroderma osteodysplastica.